University Hospital of Frankfurt (Main)
Welcome,         Profile    Billing    Logout  
 5 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Goekbuget, Nicola
NCT03109093 / 2015-000733-76: Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia

Completed
2
83
Europe
Blinatumomab, blincyto
Goethe University
ALL, Recurrent, Adult
08/21
03/23
EWALL-BOLD, NCT03480438 / 2017-002853-13: Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab

Completed
2
52
Europe
Blinatumomab, blincyto
Goethe University
B-Precursor ALL
01/24
01/24
NCT06648889: Isatuximab in Adult Patients with Cytologic or Molecular Relapsed/refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

Recruiting
2
40
Europe
Isatuximab, Bortezomib
Goethe University, Sanofi
T-ALL
02/28
08/28
GMALL-EVOLVE, NCT06061094 / 2022-000760-21: Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT

Recruiting
2
220
Europe
Imatinib, Ponatinib, Blinatumomab, Indication for stem cell transplantation
Goethe University, Deutsche Leukämie- & Lymphom-Hilfe, German Federal Ministry of Education and Research
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
07/29
07/29
GMALL-BLIVEN, NCT05182385: Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)

Recruiting
1/2
39
Europe
Blinatumomab, blincyto, Venetoclax, Venclyxto
Goethe University, University Hospital Schleswig-Holstein
ALL, Recurrent, Adult
06/25
12/25
Gökbuget, Nicola
GMALL, NCT02881086 / 2013-003466-13: Optimization of Therapy in Adult Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment

Completed
3
1000
Europe
Rituximab, Nelarabine, PEG-Asparaginase, Cranial irradiation, Imatinib, Idarubicin, Dexamethasone, Cyclophosphamide, Fludarabine, Vincristine, Mercaptopurine, VP16, Daunorubicin (DNR), Methotrexate, Stem cell transplantation, Cytarabine, Vindesine, Adriamycin, Prednisolone
Goethe University
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
12/24
12/24
INITIAL-1, NCT03460522 / 2016-004836-39: Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALL

Recruiting
2
65
Europe
Inotuzumab ozogamicin
Nicola Goekbuget, Pfizer Pharma GmbH
Precursor Cell Lymphoblastic Leukemia
06/25
12/25
GMALL-BLIVEN, NCT05182385: Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)

Recruiting
1/2
39
Europe
Blinatumomab, blincyto, Venetoclax, Venclyxto
Goethe University, University Hospital Schleswig-Holstein
ALL, Recurrent, Adult
06/25
12/25
GMALLregistry, NCT02872987: GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

Recruiting
N/A
10000
Europe
Goethe University
Acute Lymphoblastic Leukemia, Leukemia, Non-Hodgkin's Lymphoma
12/25
12/30

Download Options